Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huanghou Zhixie Diwan in Irritable Bowel Syndrome With Diarrhea
NCT07721012Phase 2Not yet recruiting
- Sponsor
- Lei Yun Shang
- Start
- Jul 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Huanghou Zhixie Diwan in Irritable bowel syndrome with diarrhea (IBS-D) (2 arms), sponsored by Lei Yun Shang. Primary endpoint: Effective rate of IBS-D (weekly response) at 4 weeks. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
Huanghou Zhixie Diwan
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT07721012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07721012.